Pharmaceutical formulation of duloxetine hydrochloride

摘要: The present invention relates to polymorphic forms of duloxetine hydrochloride, especially (duloxetine HCl), which are characterized by an X-ray diffraction pattern with peaks (2θ):9.6, 13.9, 18.0, 18.8, 19.2, 20.8, 27.4, 27.9 (designated form A) or characteristic (2θ): 12.0, 14.8, 19.8, 21.3, 21.6, 22.1, 22.4, 23.1, 24.1 T). also pertains processes for the preparation A and T, involves dissolving hydrochloride in particular solvents cooling solution obtain crystals, that dried.